{
	"kj8twc96Text": "Bri<span class=\"_ _0\"></span>nte<span class=\"_ _0\"></span>lli<span class=\"_ _0\"></span>x® r<span class=\"_ _0\"></span>edu<span class=\"_ _0\"></span>ce<span class=\"_ _0\"></span>s anxi<span class=\"_ _0\"></span>et<span class=\"_ _1\"></span>y sympto<span class=\"_ _0\"></span>ms in M<span class=\"_ _0\"></span>DD <br><span class=\"ls11 ws21\">patient<span class=\"_ _1\"></span>s<span class=\"_ _2\"></span><span class=\"fs2 ls0 wsa v1\">1<span class=\"_ _2\"></span>,2 </span></span>",
	"kj8twc97Text": "Study Design",
	"kj8twc98Text": "Mean daily dose for Brintellix® at 52 weeks 14.6mg as first trea<span class=\"_ _0\"></span>tment, 15.8mg as second treatment<br>F<span class=\"_ _2\"></span>AS: Full Analysis Set; OC: Observed cases; GAD-7 (General <span class=\"_ _0\"></span>Anxiety Disorder-7): A<span class=\"_ _0\"></span> seven-item questionnaire that measures symptom severity that is evidenced by high <br>r<span class=\"_ _0\"></span>eliability and validity as it includes key features of the DSM-IV™ criteria for generalised anxiety disorder",
	"kj8twc99Text": "Mean score",
	"kj8twc9aText": "Mean change from baseline in GAD-7 (OC)<span class=\"fs13 v5\">2</span>",
	"kj8twc9bText": "Baseline<span class=\"_ _8\"> </span>W<span class=\"_ _0\"></span>eek 4<span class=\"_ _56\"> </span>W<span class=\"_ _0\"></span>eek 8<span class=\"_ _59\"> </span>Week 12<span class=\"_ _55\"> </span>Week 26<span class=\"_ _2b\"> </span>W<span class=\"_ _0\"></span>eek 39<span class=\"_ _5a\"> </span>Week 52",
	"kj8twc9cText": "1<span class=\"fs1b ws50 v4\">st</span><span class=\"wsa\">: Brintellix® as 1<span class=\"fs1b ws50 v4\">st</span><span class=\"ws52\"> T<span class=\"_ _2\"></span>reatment (n=97)</span></span>",
	"kj8twc9dText": "Switch: Brintellix® as 2<span class=\"fs1b ws50 v4\">nd</span><span class=\"ws52\"> T<span class=\"_ _2\"></span>reatment (n=102)</span>",
	"kj8twc9eText": "F<span class=\"_ _0\"></span>AS (n=199)",
	"kj8twc9fText": "p&lt;0.001<br><span class=\"wsa\">from baseline</span>",
	"kj8twc9gText": "REVIDA<span class=\"_ _44\"> </span><span class=\"ff1 fc3 ws1e\">At-WoRC</span>",
	"kj8twc9hText": "Anxiety<span class=\"_ _5b\"></span><span class=\"ff3 fc0 wsa\">Cognitive &amp; F<span class=\"_ _0\"></span>unction<span class=\"_ _5c\"> </span><span class=\"ws4e\">Missed Work Days</span></span>",
	"Brintellix_46d32eeec8": "<span style=\"font-family: &quot;3_CCMVBT+AvenirNextLTPro-Demi&quot;; color: rgb(84, 122, 129); \">\n<font style=\"font-size: 25px;\">References</font>\n</span>",
	"Brintellix_46baf1ea2a": "<span style=\"font-family: &quot;2_PIDSIJ+AvenirNextLTPro-Regular&quot;; line-height: 1; color: rgb(100, 94, 94); display: block;\">\n<font style=\"font-size: 15px;\">\n\t<b>1.</b> Chokka P et al. CNS Spectr 2019;24:338-347.\n<br>\n</font></span>",
	"Brintellix_46f0d9bda1": "<span style=\"font-family: &quot;2_PIDSIJ+AvenirNextLTPro-Regular&quot;; line-height: 1; color: rgb(100, 94, 94); display: block;\">\n<font style=\"font-size: 15px;\">\n\t<b>2.</b> Chokka P et al. CNS Spectr 2019;25;1-12.\n<br>\n</font>\n</span>",
	"Brintellix_460ef81b93": "Text",
	"Brintellix_4665ec0b89": "Text",
	"Brintellix_466f26cd30": "Text",
	"Brintellix_462362af79": "Text",
	"Brintellix_46f2ea106c": "Text",
	"Brintellix_46f6562a3b": "<div style=\"font-family: serif;font-family: '2_VDWFON+AvenirNextLTPro-Demi';font-size: 13px;color: #4d7f86;\">RELIEVE</div>",
	"Brintellix_46abc8f0ea": "Text"
}
